StockData
Xenetic Biosciences, Inc. logo

Xenetic Biosciences, Inc. (XBIO) stock

XBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/3064% below fair value
$1.53−0.08 (-4.97%)

Close on Nov 18, 2026Market cap $3.59MP/E –Yield –

Xenetic Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Xenetic Biosciences's market cap was $4.37M on Nov 11, 2026, against $4.06M a year earlier. Over the last 5 years it ranged from $3.35M to $17.27M, with a median of $6.16M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$4.37M+30.7%
2025Dec 31, 2025$3.35M-45.6%
2024Dec 31, 2024$6.15M+16.4%
2023Dec 29, 2023$5.29M+29.5%
2022Dec 30, 2022$4.08M-76.4%
2021Dec 31, 2021$17.27M+34.4%
2020Dec 31, 2020$12.84M+58.3%
2019Dec 31, 2019$8.11M-47.4%
2018Dec 31, 2018$15.42M-7.8%
2017Dec 29, 2017$16.73M-53.1%
2016Dec 30, 2016$35.64M–

More Xenetic Biosciences figures

See a number that looks wrong?